By Mandy Jackson
Daily Journal Staff Writer
Hazel M. Aker, senior vice president, general counsel and secretary at Cadence Pharmaceuticals Inc. in San Diego, said she is fascinated by the interplay between companies' business needs and their compliance with regulatory requirements.
It's a good thing.
Since Cadence won U.S. Food and Drug Administration approval in November for its drug Ofirmev, an intravenous formulation of the pain reliev... (continued)
Sep. 18, 2011
Hazel M. Aker
Senior vice president, general counsel and secretary for Cadence Pharmaceuticals Inc. San Diego
Read more about Hazel M. Aker...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Already a subscriber?
Sign In